Stock Market News

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

May 11, 2025 - 23:20
 0
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
Read More

Tags:

Previous Article

Stock futures jump as U.S. and China conclude two days of ‘productive’ trade talks

Next Article

Stock futures surge as White House touts China trade deal

Related Posts

ANI Technologies rating downgraded at S&P due to cash burn and negative outlook

ANI Technologies rating downgraded at S&P due to cash b...

May 9, 2025  0

PPF Group aims to increase Prosiebensat.1 stake to almost 30%

PPF Group aims to increase Prosiebensat.1 stake to almo...

May 12, 2025  0

AI leaders to urge senators to speed power supply permitting, boost government data access

AI leaders to urge senators to speed power supply permi...

May 8, 2025  0